Who has invested in Xalud Therapeutics?

No investors are named on the public record for Xalud Therapeutics yet.

Xalud Therapeutics Funding: $30M Raised, Series C (2021)

Xalud Therapeutics funding overview

Xalud Therapeutics has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in August 2021. The round record for Xalud Therapeutics runs through 2021; nothing later has been disclosed.

Xalud Therapeutics at a glance

Total raised: $30M
Latest round: Series C
Latest round date: August 2021

Frequently asked about Xalud Therapeutics funding

How much has Xalud Therapeutics raised?: Xalud Therapeutics has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Xalud Therapeutics?: No investors are named on the public record for Xalud Therapeutics yet.
What was the latest Xalud Therapeutics funding round?: The most recent disclosed round is a Series C, announced in August 2021.
Where is Xalud Therapeutics based?: No headquarters location is disclosed for Xalud Therapeutics.
When did Xalud Therapeutics last raise?: The last disclosed Xalud Therapeutics round closed in August 2021 at Series C.

Round data for Xalud Therapeutics is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies and backer lists below.

Xalud Therapeutics Funding: $30M Raised, Series C (2021)

Xalud Therapeutics funding overview

Xalud Therapeutics at a glance

Frequently asked about Xalud Therapeutics funding

Companies related to Xalud Therapeutics (30)

Browse related funding lists (3)